title: Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
authors.forename: Chuanxi
authors.initials: C
authors.lastname: Fu
authors.forename: Jianxiong
authors.initials: J
authors.lastname: Xu
authors.forename: Huifeng
authors.initials: H
authors.lastname: Tan
authors.forename: Ming
authors.initials: M
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D002681:China; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D004679:Encephalomyelitis / Q000453:epidemiology / Q000473:pathology; D005260:Female; D005334:Fever / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology / Q000473:pathology; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology / Q000472:pathogenicity*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data*; D012871:Skin Diseases / Q000453:epidemiology / Q000473:pathology; D014611:Vaccination / Q000009:adverse effects; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines